Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Data Sharing Could Help Assess Effect Of Drugs On Overall Health Costs

Executive Summary

Information collected by the Centers for Medicare & Medicaid Services from Part D prescription drug plan sponsors could be used to evaluate whether providing drug coverage lowers total Medicare health care costs, the agency said in a proposed data sharing rule

You may also be interested in...



Part D Data Sharing Rule Allows External Researchers Access, With Limits

CMS will permit outside groups to access Medicare Part D data for research, but with restrictions to protect both beneficiary confidentiality and commercially sensitive information, the agency says in its final rule on Part D data sharing

Part D Data Sharing Rule Allows External Researchers Access, With Limits

CMS will permit outside groups to access Medicare Part D data for research, but with restrictions to protect both beneficiary confidentiality and commercially sensitive information, the agency says in its final rule on Part D data sharing

Part D Claims Data Sharing: Lack Of Progress Gets MedPAC’s Attention

The Medicare Payment Advisory Commission appears to be renewing its interest in shaking loose Part D claims data from CMS to help inform questions about drug access and health care quality under Medicare

UsernamePublicRestriction

Register

OM006051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel